IntelGenx Technologies Corp. 8% Convertible Unsecured Subordinated Debentures (IGX.DB) Fundamentals

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.
SHARE INFORMATION
Market Cap$ 4,905,000
Shares Outstanding54,500
Float54,500
Percent Float100.0%
Short Interest10,000.00
Short Percent Float100.0%
Short Interest Ratio1.2155
Short Interest Date2020-06-30
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,940,109
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions-
Institutional Holdings Date-
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 146.00
52 Week Low$ 76.50
52 Week High Change$ -40.00
21 Day Moving Average$ 88.1667
21 Day Extended Moving Average$ 89.9252
50 Day Moving Average$ 91.83
50 Day Extended Moving Average$ 92.421
200 Day Moving Average$ 110.9875
200 Day Extended Moving Average$ 104.3584
10 Day Average Volume-
20 Day Average Volume3,650
30 Day Average Volume2,700
50 Day Average Volume1,620
Alpha0.004306
Beta0.496774
Standard Deviation0.135458
R20.022327
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ -10.00
Quarter to Date Percent Change-10.0%
180 Day Price Change$ -40.00
180 Day Percent Change-30.77%
200 Day Price Change$ -40.00
200 Day Percent Change-30.77%
Year to Date Price Change$ -40.00
Year to Date Percent Change-30.77%

IntelGenx Technologies Corp. 8% Convertible Unsecured Subordinated Debentures (IGX.DB) Key Ratios

PROFITABILITY
EBIT Margin-738.8%
EBITDA Margin-676.7%
Pre-Tax Profit Margin-617.0%
Profit Margin Count0.0%
Gross Margin-60.4%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,624,786
Revenue Per Share$ 29.8126
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity6.42
Int Coverage-6.60
Current Ratio2.60
Leverage Ratio12.70
Quick Ratio2.40
Long Term Debt To Capital0.86
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0
Price to Sales3.0189
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.30
Invoice Turnover28.60
Assets Turnover0.10
Return Assets-71.36
Return on Equity-591.63
Return on Capital-68.43

IntelGenx Technologies Corp. 8% Convertible Unsecured Subordinated Debentures (IGX.DB) Profile

PROFILE INFO
Issue TypeBO
SEC Type-
AuditorRichter S.E.N.C.R.L./LLP
CEOHorst G. Zerbe
Emplyoees51
Last AuditUQ
CIK0001098880
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address6420 Abrams
Ville Saint Laurent, QC H4S 1Y2
Websitehttps://www.intelgenx.com
Facsimile+1 514 331-0436
Telephone+1 514 331-7440
Emailstephen@intelgenx.com
Your Recent History
TSX
IGX.DB
Intelgenx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221205 11:26:29